AWM
TCRX icon

Aries Wealth Management’s TScan Therapeutics TCRX Stock Holding History

Aries Wealth Management’s Portfolio TCRX Stock Details TCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1K Hold
10,000
– – ﹤0.01% 233
2025
Q4 		$10K Hold
10,000
– – ﹤0.01% 233
2025
Q3 		$18.2K Hold
10,000
– – ﹤0.01% 231
2025
Q2 		$14.5K Hold
10,000
– – ﹤0.01% 217
2025
Q1 		$13.8K Hold
10,000
– – ﹤0.01% 223
2024
Q4 		$30.4K Hold
10,000
– – 0.01% 216
2024
Q3 		$49.8K Hold
10,000
– – 0.01% 225
2024
Q2 		$58.5K Hold
10,000
– – 0.02% 200
2024
Q1 		$79.4K Hold
10,000
– – 0.03% 204
2023
Q4 		$58.3K Hold
10,000
– – 0.02% 195
2023
Q3 		$35.3K Buy
+10,000
New +$23.3K 0.01% 194

Other funds holding TCRX

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return